RE: November Presentation28 Nov 2018 22:01
Please read my previous posts...
I like this co and I think their focus on cosmetic surgery, bariatric surgery and IVF treatments for example are inspired.
However you cannot run ANY company if you can’t collect the receivables. I don’t agree that “120 days is the norm” for debtor days plus their strategy of expanding their business in countries like KSA and sub-Saharan Africa are only going to exacerbate the cash flow delays. Plus they’ve taken on debt and they can’t afford to let the debtor days increase much further. This is NOT a capital intensive business judging by the Board’s comments, which begs the question why a dividend of only a few pence per share is paid for a £35 share?
Legitimate questions in my opinion, that any “analyst” would sensibly ask.